- Investment Products
- IPOs
- Ambey Laboratories Ltd
Ambey Laboratories Ltd
Ambey Laboratories, founded by Mr. Anil Kumar Gupta along with Mr. Kewal Sehgal operate the business of manufacturing of agrochemical products for protecting of crops, serving the agrochemical sector. The Company is manufacturer and supplier of '2, 4-D base chemicals' with highest quality practice and compliant with Highest Environmental, Health, and Safety (EHS) in chemical industry. The manufacturing facility located in Behror, Rajasthan, has been certified with ISO 9001:2015.
Presently, the Company manufactures 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP 2,4-D Amine 866 : 720 : 480g/l SL 2,4-D Ethyl Hexyl Ester 96% TC 2,4-D Ethyl Ester 96% TC Chlorpyriphos 97%TC / 20%EC / 50%EC Thiamethoxam 96%TC / 25%WG / 75%SG Pretilachlor 95%TC / 50%EC / 37%EW Metribuzin 97%TC / 70%WS Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC and Metalaxyl 98%TC / 35%WS for our customer base which comprises of large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited; SC Formulator Co. Ltd.
The Company is proposing the Initial Public Offer aggregating 65,52,000 Equity Shares, comprising 62,40,000 through Fresh Issue and 3,12,000 through Offer for Sale.
Show more
Show less
Ambey Laboratories Ltd IPO Timeline
Ambey Laboratories Ltd IPO opens on 04-Jul-2024, and closes on 08-Jul-2024. The Ambey Laboratories Ltd IPO bid date is from 04-Jul-2024 to 08-Jul-2024. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.
| Event | Date |
|---|---|
| Ambey Laboratories Ltd IPO Opening Date | 04-Jul-2024 |
| Ambey Laboratories Ltd IPO Closing Date | 08-Jul-2024 |
| Basis of Allotment | 09-Jul-2024 |
| Initiation of Refunds | 09-Jul-2024 |
| Credit of Shares to Demat | 10-Jul-2024 |
| Ambey Laboratories Ltd IPO Listing Date | 11-Jul-2024 |
Ambey Laboratories Ltd IPO Lot Size
Ambey Laboratories Ltd IPO lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or 136000).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 2000 | ₹136000 |
| Maximum | 1 | 2000 | ₹136000 |
Ambey Laboratories Ltd IPO Details
| Ambey Laboratories Ltd IPO Date | 04-Jul-2024 to 08-Jul-2024 |
| Ambey Laboratories Ltd IPO Face Value | Shares of ₹10 per share |
| Ambey Laboratories Ltd IPO Price | ₹65 to ₹68 per share |
| Ambey Laboratories Ltd IPO Lot Size | 2000 |
| Issue Size | Shares of ₹10 (aggregating up to ₹44.68 Cr) |
| Fresh Issue | Shares of ₹10 (aggregating up to ₹42.55 Cr) |
| Offer for Sale | Shares of ₹10 (aggregating up to ₹2.12 Cr) |
| Issue Type | Book Building - SME |
| Listing At | NSE - SME |
| QIB Shares Offered | - |
| Retail Shares Offered | - |
| NII (HNI) Shares Offered | - |
| Company Promoters | Archit Gupta, Arpit Gupta, Sarina Gupta. |
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- 1 To meet out the working capital requiremnts
- 2 To meet out the general corporate purposes
Company Financials
Ambey Laboratories Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2023 | 57.62 | 107.43 | 4.57 |
| 03-2022 | 55.93 | 85.11 | 3.57 |
| 03-2021 | 44.62 | 82.42 | 10.34 |
| Amount in ₹ Crore | |||
- Experienced Management Team.
- Prime Location of its Manufacturing Facility
- Quality Assurance and Standards.
- Cordial Relationships with its Suppliers.
- A few of its properties including Registered Office of the Company, are not owned by it. In the event, the company is unable to renew the lease/ rent agreements, or if such agreements are terminated, its may suffer a disruption in the company operations.
- Rajasthan State Pollution Control Board has directed the company to deposit the amount to the tune of Rs.1,92,02,400 towards environment compensation.
- Its Board of Directors and Management may change the company operating policies and strategies without prior notice or shareholders' approval.
- Some of the raw materials that the company use as well as its finished products are hazardous, corrosive and flammable and require expert handling and storage, as applicable. Any accidents may result in loss of life or property and disrupt its operations which may have an adverse effect on the company results of operation, cash flows and financial condition.
- Its funding requirements and deployment of the issue proceeds are based on management estimates and have not been independently appraised by any bank or financial institution and actual cost may vary compared with the estimated amount.
- Substantial portion of its revenues has been dependent upon the company few clients. The loss of any one or more of its major clients would have a material adverse effect on the company's business operations and profitability.
- The Company, Promoters, Directors and group Companies are involved in certain litigations including tax related litigations, which if determined against them/it, can affect financial conditions of the company.
- The company requires a number of approvals, licenses, registration and permits for its business and failure to obtain or renew them in a timely manner may adversely affect its operations. In some cases, the company may be operating without all the required permissions, risking civil and criminal sanctions.
- Its results of operations could be adversely affected by strikes, work stoppages or increased wage demands by its employees / workers or any other kind of disputes with the company employees / workers.
- The Company has obtained insurance coverage which may not adequately cover all potential losses to which its may be subject to, and this may have a material adverse effect on its business, result of operations and financial conditions.
- The seasonality of the business of the issuer may affect the business of the issuer.
- Its business and the demand for the company products is reliant on the success of its customers' products with end consumers and any decline in the demand for the end products could have an adverse impact on its business, results of operations, cash flows and financial condition.
- Its Promoters, directors and group company has given personal guarantees in relation to certain debt facilities provided to the company.
- Its business is dependent on its manufacturing facilities and the company is subject to certain related risks. Unplanned slowdowns, unscheduled shutdowns or prolonged disruptions in its manufacturing operations or underutilization of its manufacturing capacities could have an adverse effect on the company's business, results of operations, cash flows and financial condition.
- Its existing manufacturing operation is geographically located at one place. Hence, its may face the risk of geographical non- diversification of manufacturing facilities.
- The company is subject to strict quality requirements, regular inspections and audits, and the success and wide acceptability of its products is largely dependent upon its quality controls and standards.
- Any increase in the cost of its raw material or other purchases or a shortfall in the supply of its raw materials, may adversely affect the pricing and supply of its products and have an adverse effect on the company's business, results of operations and financial condition.
- The Company has allotted Equity Shares at a price lower than the Issue Price during last 12 (twelve) months preceding the date of this Draft Red Herring Prospectus.
- The company is dependent on its management team for success whose loss could seriously impair the ability to continue to manage and expand business efficiently.
- The company has a negative cash flow in some of the previous years, details of which are given below. Sustained negative cash flow could impact its growth and business. The company has a negative cash flow in some of the previous years, details of which are given below. Sustained negative cash flow could impact its growth and business.
- The Company is reliant on certain suppliers and customers for the majority of its operations. The loss of any one or more of them would have a material adverse effect on its business operations and profitability.
- If the company is unable to establish and maintain an effective system of internal controls and compliances, its business and reputation could be adversely affected.
- The company depends on the accuracy and completeness of information about customers and counterparties and any misrepresentation, errors in or incompleteness of such information could cause its business to suffer.
- All of its product verticals are extremely competitive segments and the company faces risk of competition affecting its margins and profitability as the company scale its operations.
- Failures to procure inventory could have an adverse effect on its net sales, profitability and cash flow.
- The company could be exposed to risks arising from misconduct, fraud and trading errors by its employees and Business Associates.
- Its insurance coverage may not be sufficient or adequate to protect the company against all material hazards or business losses, which may adversely affect its business, results of operations and financial condition.
- The company has certain contingent liabilities, which, if materialized, may affect its financial condition and results of operations.
- The Company has entered into certain related party transactions and may continue to do so in the future.
- The company depends on certain brand names and its corporate name and logo that the company may not be able to protect and/or maintain.
- Changes in technology may affect its business by making its equipment or products less competitive or obsolete.
- Delays in customer payments could result in a reduction of its profits and cash flows.
- There is no monitoring agency appointed by the Company and the deployment of funds are at the discretion of its Management and the company Board of Directors, though it shall be monitored by its Audit Committee.
- One of its Director is unable to provide the company an authentic copy of her degree.
- The company has incurred substantial indebtedness which exposes it to various risks which may have an adverse effect on its business and results of operations.
- The Company has availed unsecured loans which are repayable on demand. Any demand from lenders for repayment of such unsecured loans, may adversely affect its cash flows.
- The Company has file certain forms with delayed fees and company cannot assure that no proceedings or regulatory actions will be initiated against it in relation to the non-filing and delayed filing.
- Delay in making any Statutory payments viz. Tax Deducted at Source, Income Tax, Good and Service Tax, Employee Provident Fund, ESIC or any other Statutory dues which may attract any penalty or demand raised by statutory authorities in future will affect financial position of the Company.
- Certain information contained in this Prospectus is based on management estimates and the company cannot assure you of the completeness or accuracy of the data.
- In the event there is any delay in the completion of the Issue, there would be a corresponding delay in the completion of the objects of this Issue which would in turn affect its revenues and results of operations.
- Certain of its old corporate records are not available with the company.
- Continue improving financial performance through focus on operational and functional efficiencies.
- Backward integration for Manufacturing Raw material and forward integration of Finished Goods.
- Increase in Installed Capacity.
- Leveraging its market skills, relationship and leadership position in 2, 4 D.
- Increase wallet share with existing customers and continued focus to expand customer base.
Ambey Laboratories Ltd IPO Promoter Holding
| Pre Issue Share Holding | 94.97% |
| Post Issue Share Holding | 69.89% |
Ambey Laboratories Ltd IPO Subscription Status (Bidding Detail)
The Ambey Laboratories Ltd IPO is subscribed - times on Jul 08, 2024 05:00:00 PM. The public issue subscribed - times in the retail category, - times in the QIB category, and - times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| Subscription (times) | - | - | - | - | - |
Ambey Laboratories Ltd IPO Prospectus
Ambey Laboratories Ltd IPO Listing Date
| Listing Date | 11 Jul 24 |
| BSE Script | 92828 |
| NSE Symbol | AMBEY |
| Listing In | NSE - SME |
| ISIN | INE0M3I01029 |
| IPO Price | ₹68 |
| Face Value | ₹10 |
Ambey Laboratories Ltd IPO Registrar
Link Intime India Pvt Ltd
Phone: +91 8108114949
Email: ambeylab.ipo@linkintime.co.in
Website: www.linkintime.co.in
Ambey Laboratories Ltd IPO Lead Manager(s)
- Fast Track Finsec Pvt Ltd
FAQs on Ambey Laboratories Ltd IPO
Ambey Laboratories Ltd IPO, which opens for subscription from 04-Jul-2024 to 08-Jul-2024 has an issue size of ₹44.68 crore. The issue type is book building issue.
In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for Ambey Laboratories Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.
Ambey Laboratories Ltd IPO Opens for subscription from 04-Jul-2024 to 08-Jul-2024.
The lot size of Ambey Laboratories Ltd is 2000 shares. Retail investors can subscribe to minimum 1 lot and maximum 1 lots. The minimum and maximum application value is ₹136000 and ₹136000 respectively.
Allotment date for Ambey Laboratories Ltd is 09-Jul-2024 and refund of application amount (in case allotment is not received) will begin from 09-Jul-2024. If your allotment goes through, then shares will be credited in your Demat account by 10-Jul-2024.
The registrar for Ambey Laboratories Ltd IPO is Link Intime India Pvt Ltd. You can check your IPO allotment status on the registrar's website.
The shares of Ambey Laboratories Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Power your investments with our smart trading platforms
For a powerful, stable and secure experience,
download m.Stock App & set up your lifetime Zero brokerage account @ one-time fee of ₹999
-
Scan QR code to download
- OR
-
Enter number to get app link
+91
